AU6460400A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU6460400A
AU6460400A AU64604/00A AU6460400A AU6460400A AU 6460400 A AU6460400 A AU 6460400A AU 64604/00 A AU64604/00 A AU 64604/00A AU 6460400 A AU6460400 A AU 6460400A AU 6460400 A AU6460400 A AU 6460400A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64604/00A
Inventor
John Dixon
Philip Ronald Holt
Francis Ince
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
AstraZeneca UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca UK Ltd filed Critical AstraZeneca UK Ltd
Publication of AU6460400A publication Critical patent/AU6460400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
AU64604/00A 1999-08-18 2000-08-14 Pharmaceutical compositions Abandoned AU6460400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9902935A SE9902935D0 (en) 1999-08-18 1999-08-18 Pharmaceutical compositions
SE9902935 1999-08-18
PCT/GB2000/003118 WO2001012167A2 (en) 1999-08-18 2000-08-14 Pharmaceutical compositions comprising a 7-(2-aminoethyl)-benzothiazolone and an anticholinergic muscarinic antagonist

Publications (1)

Publication Number Publication Date
AU6460400A true AU6460400A (en) 2001-03-13

Family

ID=20416693

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64604/00A Abandoned AU6460400A (en) 1999-08-18 2000-08-14 Pharmaceutical compositions

Country Status (3)

Country Link
AU (1) AU6460400A (en)
SE (1) SE9902935D0 (en)
WO (1) WO2001012167A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DE10063957A1 (en) * 2000-12-20 2002-06-27 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics and dopamine agonists
DE10111843A1 (en) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Compounds for the treatment of inflammatory diseases
DE602004021959D1 (en) 2003-11-21 2009-08-20 Theravance Inc COMPOUNDS OF AGONISTIC EFFECT ON THE BETA2 ADRENEER RECEPTOR AND THE MUSCARIN RECIPE
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702385D0 (en) * 2007-02-07 2007-03-21 Argenta Discovery Ltd New combination
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
TW201002696A (en) 2008-06-18 2010-01-16 Astrazeneca Ab Novel compounds 409
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds

Also Published As

Publication number Publication date
WO2001012167A3 (en) 2001-09-20
WO2001012167A2 (en) 2001-02-22
SE9902935D0 (en) 1999-08-18

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU3192700A (en) Medicinal compositions
HUP0202513A2 (en) Betha-carboline pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU1071301A (en) Pharmaceutical compounds
GB0028088D0 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
AU3556400A (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
GB9923436D0 (en) Pharmaceutical compositions
AU1887401A (en) Medicinal composition
AU4328800A (en) Pharmaceutical formulation
AU1735001A (en) Cyclodextrin-containing pharmaceutical composition
AU6715600A (en) Pharmaceutical formulations
GB9904163D0 (en) Pharmaceutical compositions
AU4304400A (en) Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
AU6460400A (en) Pharmaceutical compositions
AU5460800A (en) Pharmaceutical transdermal compositions
AU2001273919A1 (en) Pharmaceutical compositions
GB9911017D0 (en) Pharmaceutical compositions
AU2681500A (en) Rapidly-soluble compositions
AU4977300A (en) Pharmaceutical formulations
AU6460200A (en) Pharmaceutical compositions
AU1385801A (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase